Cargando…

Preeclampsia Status Controls Interleukin-6 and Soluble IL-6 Receptor Release from Neutrophils and Endothelial Cells: Relevance to Increased Inflammatory Responses

Increased neutrophil–endothelial binding and inflammatory responses are significant pathophysiological events in the maternal vascular system in preeclampsia, a hypertensive disorder in human pregnancy. Interleukin 6 (IL-6) and its soluble receptors (soluble IL-6R (sIL-6R) and soluble gp130 (sgp130)...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Yuping, Gu, Yang, Alexander, J. Steven, Lewis, David F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830466/ https://www.ncbi.nlm.nih.gov/pubmed/35366257 http://dx.doi.org/10.3390/pathophysiology28020013

Ejemplares similares

The function of the soluble interleukin 6 (IL-6) receptor in vivo: sensitization of human soluble IL-6 receptor transgenic mice towards IL- 6 and prolongation of the plasma half-life of IL-6
Publicado: (1996)

Placental Growth Factor, Soluble fms-Like Tyrosine Kinase 1, Soluble Endoglin, IL-6, and IL-16 as Biomarkers in Preeclampsia
por: Rădulescu, Carmen, et al.
Publicado: (2016)

Maternal serum iron status, hepcidin and interleukin-6 levels in women with preeclampsia
por: Ahmed, Yasir I. B., et al.
Publicado: (2023)

IL-6 Trans-Signaling via the Soluble IL-6 Receptor: Importance for the Pro-Inflammatory Activities of IL-6
por: Rose-John, Stefan
Publicado: (2012)

Evaluation of interleukin-6 and its soluble receptor components sIL-6R and sgp130 as markers of inflammation in inflammatory bowel diseases
por: Nikolaus, Susanna, et al.
Publicado: (2018)

Recombinant Production of a Mutant Form of Soluble IL-6 Receptor with Inhibitory Effects against Interleukin-6
por: Feghhi-najafabadi, Saba, et al.
Publicado: (2022)

Relevance of Inflammatory Cytokine mRNA Expression of Tumour Necrosis Factor- Alpha (TNF α), Interleukin 17A (IL 17A) and Interleukin 6 (IL 6) in Indian Patients with Psoriasis
por: Shah, Saiqa R., et al.
Publicado: (2022)

Special issue on Interleukin-6 (IL-6)
por: Rincon, Mercedes
Publicado: (2012)

Evaluation of the Association of Single Nucleotide Polymorphism rs2229238 in Interleukin 6 Receptor Alpha (IL6RA) Gene With the Risk of Preeclampsia
por: Sivaraj, Nagarjuna, et al.
Publicado: (2022)

Soluble Interleukin‐6 Receptor Is Released from Receptor‐bearing Cell Lines in vitro
por: Nakajima, Toshiharu, et al.
Publicado: (1992)

Role of interleukin-15 and interleukin-18 in the secretion of sIL-6R and sgp130 by human neutrophils.
por: Jablonska, E, et al.
Publicado: (2003)

Comparing nanobody and aptamer-based capacitive sensing for detection of interleukin-6 (IL-6) at physiologically relevant levels
por: Sánchez-Salcedo, Raquel, et al.
Publicado: (2023)

Perturbation of the Actin Cytoskeleton in Human Hepatoma Cells Influences Interleukin-6 (IL-6) Signaling, but Not Soluble IL-6 Receptor Generation or NF-κB Activation
por: Georgieva, Elizabeta, et al.
Publicado: (2021)

Interleukin (IL)-6 Inhibits IL-27- and IL-30-Mediated Inflammatory Responses in Human Monocytes
por: Petes, Carlene, et al.
Publicado: (2018)

Interleukin-6 and pro inflammatory status in the breast tumor microenvironment
por: Sanguinetti, Alessandro, et al.
Publicado: (2015)

Ga(III) Nanoparticles Inhibit Growth of both Mycobacterium tuberculosis and HIV and Release of Interleukin-6 (IL-6) and IL-8 in Coinfected Macrophages
por: Choi, Seoung-ryoung, et al.
Publicado: (2017)

Interleukin-6 in Schizophrenia—Is There a Therapeutic Relevance?
por: Borovcanin, Milica Milovan, et al.
Publicado: (2017)

Serum levels of interleukin-6 type cytokines and soluble interleukin-6 receptor in patients with rheumatoid arthritis.
por: Robak, T, et al.
Publicado: (1998)

Soluble Interleukin-6 Receptor Regulates Interleukin-6-Dependent Vascular Remodeling in Long-Distance Runners
por: Villar-Fincheira, Paulina, et al.
Publicado: (2021)

The correlations of serum interleukin-6 (il-6) levels and serum soluble il-6 receptor levels with disease activity in systemic juvenile idiopathic arthritis patients with and without tocilizumab treatment
por: Lerkvaleekul, Butsabong, et al.
Publicado: (2014)

Clinical Relevance of Serum Vascular Endothelial Growth Factor and Interleukin-6 in Patients With Colorectal Cancer
por: Alzoghaibi, Mohammad
Publicado: (2011)

Clinical Relevance of Serum Vascular Endothelial Growth Factor and Interleukin-6 in Patients with Colorectal Cancer
por: Eldesoky, Ayman, et al.
Publicado: (2011)

Interleukin-6-knockdown of chimeric antigen receptor-modified T cells significantly reduces IL-6 release from monocytes
por: Kang, Liqing, et al.
Publicado: (2020)

Role of interleukin 4 (IL4) and interleukin 6 (IL6) in the pathogenesis and prognosis of childhood primary immune thrombocytopenia
por: Zakaria, Marwa, et al.
Publicado: (2023)

Association of serum interleukin-6 and soluble interleukin-2-receptor levels with disease activity status in patients with inflammatory bowel disease: A prospective observational study
por: Mavropoulou, Eirini, et al.
Publicado: (2020)

The Role of Interleukin-6 (IL-6) in the Systemic Inflammatory Response in Xenograft Recipients and in Pig Kidney Xenograft Failure
por: Zhang, Guoqiang, et al.
Publicado: (2021)

Podocytes Regulate Neutrophil Recruitment by Glomerular Endothelial Cells via IL-6–Mediated Crosstalk
por: Kuravi, Sahithi J., et al.
Publicado: (2014)

Cathepsin S provokes interleukin-6 (IL-6) trans-signaling through cleavage of the IL-6 receptor in vitro
por: Flynn, Charlotte M., et al.
Publicado: (2020)

Role of interleukin-6 (IL-6) in predicting gestational diabetes mellitus
por: Amirian, Azam, et al.
Publicado: (2020)

Interleukin‐6 signaling requires only few IL‐6 molecules: Relation to physiological concentrations of extracellular IL‐6
por: Hansen, Morten B.
Publicado: (2020)

A Role for Soluble IL-6 Receptor in Osteoarthritis
por: Akeson, Graham, et al.
Publicado: (2017)

Clinical significance of interleukin (IL)-6 in cancer metastasis to bone: potential of anti-IL-6 therapies
por: Tawara, Ken, et al.
Publicado: (2011)

Structural Mimicry of Receptor Interaction by Antagonistic Interleukin-6 (IL-6) Antibodies
por: Blanchetot, Christophe, et al.
Publicado: (2016)

Interleukin-6 (IL-6) Receptor Antagonist Protects Against Rheumatoid Arthritis
por: Li, Songsong, et al.
Publicado: (2016)

Tocilizumab does not block interleukin-6 (IL-6) signaling in murine cells
por: Lokau, Juliane, et al.
Publicado: (2020)

Emerging Role of Endothelial and Inflammatory Markers in Preeclampsia
por: Swellam, Menha, et al.
Publicado: (2009)

Inhibition of IL-6+IL-6 soluble receptor-stimulated aromatase activity by the IL-6 antagonist, Sant 7, in breast tissue-derived fibroblasts
por: Purohit, A, et al.
Publicado: (2003)

IL-27 Activates Human Trophoblasts to Express IP-10 and IL-6: Implications in the Immunopathophysiology of Preeclampsia
por: Yin, Nanlin, et al.
Publicado: (2014)

Interleukin-6 Receptor Polymorphism Is Prevalent in HIV-negative Castleman Disease and Is Associated with Increased Soluble Interleukin-6 Receptor Levels
por: Stone, Katie, et al.
Publicado: (2013)

Assessment of Interleukins IL-4, IL-6, IL-8, IL-10 in Acute Urticaria
por: Papadopoulos, Jordan, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_51t0a4abqs5gsnc2vbaja25f1v